Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ

Therapies targeting inflammation reveal inconsistent results in idiopathic pulmonary fibrosis (IPF). Aerosolised interferon (IFN)-γ has been proposed as a novel therapy. Changes in the host airway microbiome are associated with the inflammatory milieu and may be associated with disease progression....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Lesko, Melissa, Badri, Michelle H., Kapoor, Bianca C., Wu, Benjamin G., Li, Yonghua, Smaldone, Gerald C., Bonneau, Richard, Kurtz, Zachary D., Condos, Rany, Segal, Leopoldo N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507144/
https://www.ncbi.nlm.nih.gov/pubmed/28717640
http://dx.doi.org/10.1183/23120541.00008-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507144/
https://www.ncbi.nlm.nih.gov/pubmed/28717640
http://dx.doi.org/10.1183/23120541.00008-2017

Ejemplares similares